These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 3145353)
1. A multicomponent Pseudomonas aeruginosa vaccine consisting of toxoids of protease, elastase, exotoxin A and a common protective antigen (OEP): basic concept of vaccination and prospect of clinical application. Homma JY; Tanimoto H Kitasato Arch Exp Med; 1988 Sep; 61(2-3):81-93. PubMed ID: 3145353 [No Abstract] [Full Text] [Related]
2. Antibody titers in serum of diffuse panbronchiolitis patients administered a multicomponent Pseudomonas aeruginosa vaccine consisting of toxoids of protease, elastase and exotoxin A and a common protective antigen (OEP). Yamamoto M; Kubota Y; Matsuura M; Homma JY Kitasato Arch Exp Med; 1988 Sep; 61(2-3):127-35. PubMed ID: 3145352 [No Abstract] [Full Text] [Related]
3. A multicomponent Pseudomonas aeruginosa vaccine consisting of toxoids of protease, elastase, exotoxin A and a common protective antigen (OEP). Application in patients with diffuse panbronchiolitis. Homma JY; Tanimoto H Antibiot Chemother (1971); 1987; 39():215-21. PubMed ID: 3118783 [No Abstract] [Full Text] [Related]
4. [Antibody titers in the serum of patients vaccinated with the multicomponent vaccine consisting of toxoids of protease, elastase and a common protective antigen (OEP)]. Yamamoto M; Kubota Y; Matsuura M; Homma JY Kansenshogaku Zasshi; 1986 Nov; 60(11):1178-83. PubMed ID: 3102639 [No Abstract] [Full Text] [Related]
5. Efficacies of alkaline protease, elastase and exotoxin A toxoid vaccines against gut-derived Pseudomonas aeruginosa sepsis in mice. Matsumoto T; Tateda K; Furuya N; Miyazaki S; Ohno A; Ishii Y; Hirakata Y; Yamaguchi K J Med Microbiol; 1998 Apr; 47(4):303-8. PubMed ID: 9568995 [TBL] [Abstract][Full Text] [Related]
6. [Prevelance of antibodies ot OEP, exotoxin A, and exoenzymes of Pseudomonas aeruginosa in man (author's transl)]. Shinozaki T; Fujii R; Sanai Y; Homma JY Kansenshogaku Zasshi; 1981 Jan; 55(1):32-40. PubMed ID: 6788869 [No Abstract] [Full Text] [Related]
7. Prospective study of serum antibodies to Pseudomonas aeruginosa exoproteins in cystic fibrosis. Hollsing AE; Granström M; Vasil ML; Wretlind B; Strandvik B J Clin Microbiol; 1987 Oct; 25(10):1868-74. PubMed ID: 3117842 [TBL] [Abstract][Full Text] [Related]
9. A polyvalent Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine. Cryz SJ; Fürer E; Sadoff JC; Germanier R Antibiot Chemother (1971); 1987; 39():249-55. PubMed ID: 3118786 [No Abstract] [Full Text] [Related]
10. [The significance of bacterial and host factors in corneal infections caused by Pseudomonas aeruginosa]. Steuhl KP; Döring G; Thiel HJ Fortschr Ophthalmol; 1989; 86(4):283-6. PubMed ID: 2507425 [TBL] [Abstract][Full Text] [Related]
11. Serum antibody concentrations of cytotoxin, exotoxin, A, lipopolysaccharide, protease, and elastase and survival of patients with Pseudomonas aeruginosa bacteremia. Baltch AL; Franke M; Smith RP; Asperilla M; Griffin P; Michelsen P; Lutz F Clin Infect Dis; 1996 Nov; 23(5):1109-16. PubMed ID: 8922810 [TBL] [Abstract][Full Text] [Related]
12. Is Pseudomonas aeruginosa exotoxin A a good carrier protein for conjugate vaccines? Pier GB Hum Vaccin; 2007; 3(2):39-40; author reply 41. PubMed ID: 17268204 [No Abstract] [Full Text] [Related]
13. Development of antibodies to OEP, exotoxin A and exoenzymes of Pseudomonas aeruginosa in man. Shinozaki T; Fujii R; Sanai Y; Homma JY Jpn J Exp Med; 1981 Jun; 51(3):165-70. PubMed ID: 6795373 [TBL] [Abstract][Full Text] [Related]
14. Vaccine efficacies of elastase, exotoxin A, and outer-membrane protein F in preventing chronic pulmonary infection by Pseudomonas aeruginosa in a rat model. Gilleland HE; Gilleland LB; Fowler MR J Med Microbiol; 1993 Feb; 38(2):79-86. PubMed ID: 8429543 [TBL] [Abstract][Full Text] [Related]
15. [Protective properties of anatoxin obtained from a homogeneous preparation of Pseudomonas aeruginosa exotoxin A]. Brodinova NS; Vovk VA; Aleksandrov AD; Moroz AF Zh Mikrobiol Epidemiol Immunobiol; 1989 Jun; (6):3-8. PubMed ID: 2508376 [TBL] [Abstract][Full Text] [Related]
16. Pseudomonas aeruginosa antibody detection in cystic fibrosis patients. Trancassini M; De Vito D; Quattrucci S; Cipriani P New Microbiol; 1999 Apr; 22(2):85-9. PubMed ID: 10322606 [TBL] [Abstract][Full Text] [Related]
17. Dual-function vaccine for Pseudomonas aeruginosa: characterization of chimeric exotoxin A-pilin protein. Hertle R; Mrsny R; Fitzgerald DJ Infect Immun; 2001 Nov; 69(11):6962-9. PubMed ID: 11598071 [TBL] [Abstract][Full Text] [Related]
18. Effect of Pseudomonas aeruginosa elastase, alkaline protease, and exotoxin A on corneal proteinases and proteins. Twining SS; Kirschner SE; Mahnke LA; Frank DW Invest Ophthalmol Vis Sci; 1993 Aug; 34(9):2699-712. PubMed ID: 8344792 [TBL] [Abstract][Full Text] [Related]